Related Experiment Video
Updated: May 4, 2026

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
Published on: September 16, 2022
Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms
Nicolas Delattin1, Bruno P A Cammue, Karin Thevissen
1Centre of Microbial & Plant Genetics, Katholieke Universiteit Leuven, Kasteelpark Arenberg 20, 3001 Heverlee, Belgium.
Abstract:
Invasive fungal infections are associated with very high mortality rates ranging from 20-90% for opportunistic fungal pathogens such as Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus. Fungal resistance to antimycotic treatment can be genotypic (due to resistant strains) as well as phenotypic (due to more resistant fungal lifestyles, such as biofilms). With regard to the latter, biofilms are considered to be critical in the development of invasive fungal infections. However, there are only very few antimycotics, such as miconazole (azoles), echinocandins and liposomal formulations of amphotericin B (polyenes), which are also effective against fungal biofilms. Interestingly, these antimycotics all induce reactive oxygen species (ROS) in fungal (biofilm) cells. This review provides an overview of the different classes of antimycotics and novel antifungal compounds that induce ROS in fungal planktonic and biofilm cells. Moreover, different strategies to further enhance the antibiofilm activity of such ROS-inducing antimycotics will be discussed.
Insights
Invasive fungal infections are deadly, and resistance is a major issue. This review explores antifungal drugs that combat fungal biofilms by inducing reactive oxygen species (ROS).
Area of Science:
- Mycology
- Infectious Diseases
- Pharmacology
Background:
- Invasive fungal infections cause high mortality (20-90%) due to opportunistic pathogens like Candida albicans.
- Fungal resistance to antifungals arises from genotypic (resistant strains) and phenotypic (biofilms) factors.
- Biofilms are critical in invasive fungal infections, yet few antifungals are effective against them.
Purpose of the Study:
- To review antimycotics and novel compounds that induce reactive oxygen species (ROS) in fungal planktonic and biofilm cells.
- To discuss strategies for enhancing the antibiofilm activity of ROS-inducing antifungals.
Main Methods:
- Literature review of existing studies on antimycotics and fungal biofilms.
- Analysis of the mechanism of action of ROS-inducing antifungal compounds.
- Exploration of synergistic strategies to improve antibiofilm efficacy.
Main Results:
- Several classes of antimycotics, including azoles, echinocandins, and amphotericin B, induce ROS in fungal cells.
- ROS induction is a key mechanism for the antibiofilm activity of certain antifungals.
- The effectiveness of these antifungals against biofilms is limited but significant.
Conclusions:
- Antimycotics that induce ROS represent a promising avenue for combating fungal biofilms.
- Further research into enhancing ROS-mediated antifungal activity is crucial for developing new treatments.
- Targeting ROS production offers a potential strategy to overcome antifungal resistance in biofilms.
Related Concept Videos
Antifungal Agents
Chemical Agents for Microbial Control
Antimicrobial Effectiveness
Biofilms
Oxygen Requirements and Growth Patterns
Bioactivation and Tissue Toxicity

